EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression

Mei Li, Ya Nan Xu, Xiulan Su, Jianxun Wen

PeerJ · 18.08.2026 · 14 · e21570

DOI: 10.7717/peerj.21570 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PeerJ, online erschienen am 18.08.2026. Verfasst von Mei Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology Research, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China. Hauptthemen laut MEDLINE: Glycine Hydroxymethyltransferase, Neoplasms. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Inner Mongolia, Innovation and Entrepreneurship Training Program for College Students, Inner Mongolia Medical University, The Talent cultivation project for student of inner Mongolia medical university.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SHMT2 (serine hydroxymethyltransferase 2) is a pivotal enzyme in cellular metabolism and is closely associated with the initiation and progression of malignant tumors, garnering significant attention in cancer research and therapy. Aberrant expression of SHMT2 has been observed in various cancers, correlating with tumor aggressiveness and patient prognosis. Functionally, SHMT2 participates in one-carbon metabolism, supplying methyl donors and biosynthetic precursors to support tumor cell proliferation. Additionally, it modulates redox homeostasis, promoting cancer cell survival and progression. SHMT2 also interacts with key signaling pathways, including JAK2/STAT3 and Akt/mTOR, thereby influencing tumor cell growth, invasion, and metastasis. Further elucidation of the molecular mechanisms by which SHMT2 contributes to tumorigenesis may provide critical insights for precision diagnosis, targeted therapy, and prognostic evaluationin oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycine HydroxymethyltransferaseNeoplasmsHumansDisease ProgressionSignal TransductionCell ProliferationAnimalsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Regulatory mechanismSHMT2Therapeutic targetTumor growth

Substanzen

Glycine HydroxymethyltransferaseSHMT protein, human

Autor:innen und Institutionen

  • Center for Clinical Epidemiology Research, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Public Service Center for Medical Research, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.

Förderung

  • Natural Science Foundation of Inner Mongolia
  • Innovation and Entrepreneurship Training Program for College Students, Inner Mongolia Medical University
  • The Talent cultivation project for student of inner Mongolia medical university

Zitieren

APA

Li, M., Xu, Y. N., Su, X., & Wen, J. (2026). Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression. PeerJ, 14, e21570. https://doi.org/10.7717/peerj.21570

Vancouver

Li M, Xu YN, Su X, Wen J. Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression. PeerJ. 2026;14:e21570. doi:10.7717/peerj.21570

BibTeX
@article{Li2026,
  author = {Li, Mei and Xu, Ya Nan and Su, Xiulan and Wen, Jianxun},
  title = {Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21570},
  doi = {10.7717/peerj.21570}
}
Kostenlos starten →